Tag: Anticoagulants
Early Anticoagulation May Not Up Survival in Severe COVID-19
Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients
Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
Interim results show improvement in primary end point of need for ventilation, other organ-supportive interventions
Anticoagulants Not Tied to Higher Risk for GI Bleed in COVID-19
3 percent of hospitalized COVID-19 patients experience gastrointestinal bleeding
Ongoing Anticoagulant Use Does Not Avert Severe COVID-19
No reduction seen in risks for hospital admission, intensive care unit admission, or death due to COVID
High-Dose Anticoagulation May Not Aid COVID-19 Patients
No significant benefit seen for high-dose versus standard anticoagulation therapies, may be harmful
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
Benefit only seen for composite outcome, not for major or minor bleeding incidents
Mortality, Intubation Rates Lower With Anticoagulation in COVID-19
Thromboembolic disease that was not suspected clinically identified in 42 percent of autopsies
High Rates of DVT Seen in Critically Ill COVID-19 Patients
Authors call for prompt detection and early anticoagulant therapy
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
